Dopamine receptor-modulated [ 35 S ]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats

[1]  J. Maloteaux,et al.  Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding. , 1999, Life sciences.

[2]  K. Fuxe,et al.  Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes. , 1999, Biochemical pharmacology.

[3]  T. Koyama,et al.  Receptor-mediated and receptor-independent activation of G-proteins in rat brain membranes. , 1998, Life sciences.

[4]  M. Koelle.  A new family of G-protein regulators - the RGS proteins. , 1997, Current opinion in cell biology.

[5]  M. Besson,et al.  Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons , 1997, Neuroreport.

[6]  H. Wang,et al.  Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. , 1995, The Journal of pharmacology and experimental therapeutics.

[7]  H. Wang,et al.  Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  S. Hyman,et al.  6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Robertson,et al.  The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat — an autoradiographic study , 1994, Brain Research.

[10]  R. Sullivan,et al.  Striatal G-proteins: Effects of unilateral 6-hydroxydopamine lesions , 1994, Neuroscience Letters.

[11]  U. Schwabe,et al.  Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding. , 1993, Molecular pharmacology.

[12]  C. Verney,et al.  G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  E. Friedman,et al.  Repeated Reserpine Increases Striatal Dopamine Receptor and Guanine Nucleotide Binding Protein RNA , 1993, Journal of neurochemistry.

[14]  O. Meucci,et al.  Modulation by GTP of Basal and Agonist‐Stimulated Striatal Adenylate Cyclase Activity Following Chronic Blockade of D1 and D2 Dopamine Receptors: Involvement of G Proteins in the Development of Receptor Supersensitivity , 1992, Journal of neurochemistry.

[15]  G. Lahoste,et al.  Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density , 1992, Synapse.

[16]  C. Marsden,et al.  Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. , 1992, Biochemical pharmacology.

[17]  C. Sánchez,et al.  Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. , 1992, European journal of pharmacology.

[18]  G. Lahoste,et al.  Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: Autoradiographic evidence against the dual mechanism hypothesis , 1991, Neuroscience.

[19]  M. Schumacher,et al.  Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. , 1991, Brain research. Molecular brain research.

[20]  R. Cowburn,et al.  Enhanced adenylate cyclase activity in neonatally dopamine lesioned rats is related to increased Gs-protein coupling. , 1991, European journal of pharmacology.

[21]  X.-T. Hu,et al.  Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  A. Enz,et al.  Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. , 1990, Molecular pharmacology.

[23]  Philip M. Groves,et al.  Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behavior , 1981, Brain Research.

[24]  R. Mishra,et al.  Supersensitivity in rat caudate nucleus: Effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes , 1980, Brain Research.

[25]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[26]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[27]  R. Katzman.,et al.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[28]  U. Ungerstedt,et al.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. , 1970, Brain research.

[29]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[30]  D. Sibley,et al.  Regulation of Dopamine Receptor Function and Expression , 1997 .

[31]  E. R. Marcotte,et al.  G Proteins and Animal Models of Parkinson’s Disease , 1997 .

[32]  H. Ueda,et al.  Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  H. Yamane,et al.  Covalent modifications of G-proteins. , 1993, Annual review of pharmacology and toxicology.

[34]  S. Lazareno,et al.  Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. , 1993, Life sciences.

[35]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .